Abstract

The emergence of antibiotic resistance among pathogenic and commensal bacteria has become a serious problem worldwide. Use and overuse of antibiotics in a number of settings are contributing to the development of antibiotic-resistant microorganisms (1). Recently, the rate of discovery of new compounds from existing genera obtained from terrestrial sources has decreased, while the rate of re-isolation of known compounds has increased. Moreover, rise in the number of drug-resistant pathogens and limited success of strategies such as combinatorial chemistry in providing new agents indicates an uncertain forecast for future antimicrobial therapy (2, 3). Thus, it is critical that new groups of microbes from unexplored habitats be pursued as sources of novel antibiotics and other small-molecule therapeutic agents(4). In the present study 36 bacterial and 24 fungal isolates from different aqua to terrestrial sources were grown in broth culture for production of metabolites. The intracellular metabolites were extracted with methanol and extracellular metabolites were extracted with ethyl acetate. The crude intra and extracellular extracts were evaluated for antimicrobial activity by agar diffusion method using various bacterial and fungal test organisms. Ciprofloxacin (100 μg/ml) was used as standard for antibacterial studies and Nystatin disc (10 μg/disc) was used for antifungal studies. It was found that the isolate UG-3 (extracellular extract) showed both antibacterial and antifungal activity against all the test organisms employed. UG-6 was also equally promising, except that E.coli was resistant to the extracellular extract of UG-6. Intracellular extracts of MC-1, E-1, LS-4 , PSA-2 and extracellular extracts of M-4. LS-3F, GS-4, VHSS-2, LS-3XY, VHSP-5, PSA-3 were found to be active against all test organisms except Candida albicans. Extracellular extract of GS-1 and intracellular extracts of G-1, G-5, and K2A were found to be active against all test bacteria employed.

Original languageEnglish
Pages (from-to)111-126
Number of pages16
JournalPharmacologyonline
Volume1
Publication statusPublished - 2009

Fingerprint

Ecosystem
Anti-Bacterial Agents
Bacteria
Nystatin
Ciprofloxacin
Microbial Drug Resistance
Candida albicans
Agar
Methanol
Escherichia coli
Therapeutics
Pharmaceutical Preparations
Extremophiles
ethyl acetate

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery

Cite this

@article{48c7b8efa92746a2a1e0e18829554e3c,
title = "Antimicrobial profile of extremophiles from aqua to terrestrial habitats",
abstract = "The emergence of antibiotic resistance among pathogenic and commensal bacteria has become a serious problem worldwide. Use and overuse of antibiotics in a number of settings are contributing to the development of antibiotic-resistant microorganisms (1). Recently, the rate of discovery of new compounds from existing genera obtained from terrestrial sources has decreased, while the rate of re-isolation of known compounds has increased. Moreover, rise in the number of drug-resistant pathogens and limited success of strategies such as combinatorial chemistry in providing new agents indicates an uncertain forecast for future antimicrobial therapy (2, 3). Thus, it is critical that new groups of microbes from unexplored habitats be pursued as sources of novel antibiotics and other small-molecule therapeutic agents(4). In the present study 36 bacterial and 24 fungal isolates from different aqua to terrestrial sources were grown in broth culture for production of metabolites. The intracellular metabolites were extracted with methanol and extracellular metabolites were extracted with ethyl acetate. The crude intra and extracellular extracts were evaluated for antimicrobial activity by agar diffusion method using various bacterial and fungal test organisms. Ciprofloxacin (100 μg/ml) was used as standard for antibacterial studies and Nystatin disc (10 μg/disc) was used for antifungal studies. It was found that the isolate UG-3 (extracellular extract) showed both antibacterial and antifungal activity against all the test organisms employed. UG-6 was also equally promising, except that E.coli was resistant to the extracellular extract of UG-6. Intracellular extracts of MC-1, E-1, LS-4 , PSA-2 and extracellular extracts of M-4. LS-3F, GS-4, VHSS-2, LS-3XY, VHSP-5, PSA-3 were found to be active against all test organisms except Candida albicans. Extracellular extract of GS-1 and intracellular extracts of G-1, G-5, and K2A were found to be active against all test bacteria employed.",
author = "Thomas, {Angel Treasa} and Rao, {J. Venkata} and Mathew, {Aranjani Jesil} and Subrahmanyam, {V. M.} and Kamath, {B. Venkatesh} and N. Udupa",
year = "2009",
language = "English",
volume = "1",
pages = "111--126",
journal = "Pharmacologyonline",
issn = "1827-8620",
publisher = "SILAE (Italo-Latin American Society of Ethnomedicine)",

}

Antimicrobial profile of extremophiles from aqua to terrestrial habitats. / Thomas, Angel Treasa; Rao, J. Venkata; Mathew, Aranjani Jesil; Subrahmanyam, V. M.; Kamath, B. Venkatesh; Udupa, N.

In: Pharmacologyonline, Vol. 1, 2009, p. 111-126.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Antimicrobial profile of extremophiles from aqua to terrestrial habitats

AU - Thomas, Angel Treasa

AU - Rao, J. Venkata

AU - Mathew, Aranjani Jesil

AU - Subrahmanyam, V. M.

AU - Kamath, B. Venkatesh

AU - Udupa, N.

PY - 2009

Y1 - 2009

N2 - The emergence of antibiotic resistance among pathogenic and commensal bacteria has become a serious problem worldwide. Use and overuse of antibiotics in a number of settings are contributing to the development of antibiotic-resistant microorganisms (1). Recently, the rate of discovery of new compounds from existing genera obtained from terrestrial sources has decreased, while the rate of re-isolation of known compounds has increased. Moreover, rise in the number of drug-resistant pathogens and limited success of strategies such as combinatorial chemistry in providing new agents indicates an uncertain forecast for future antimicrobial therapy (2, 3). Thus, it is critical that new groups of microbes from unexplored habitats be pursued as sources of novel antibiotics and other small-molecule therapeutic agents(4). In the present study 36 bacterial and 24 fungal isolates from different aqua to terrestrial sources were grown in broth culture for production of metabolites. The intracellular metabolites were extracted with methanol and extracellular metabolites were extracted with ethyl acetate. The crude intra and extracellular extracts were evaluated for antimicrobial activity by agar diffusion method using various bacterial and fungal test organisms. Ciprofloxacin (100 μg/ml) was used as standard for antibacterial studies and Nystatin disc (10 μg/disc) was used for antifungal studies. It was found that the isolate UG-3 (extracellular extract) showed both antibacterial and antifungal activity against all the test organisms employed. UG-6 was also equally promising, except that E.coli was resistant to the extracellular extract of UG-6. Intracellular extracts of MC-1, E-1, LS-4 , PSA-2 and extracellular extracts of M-4. LS-3F, GS-4, VHSS-2, LS-3XY, VHSP-5, PSA-3 were found to be active against all test organisms except Candida albicans. Extracellular extract of GS-1 and intracellular extracts of G-1, G-5, and K2A were found to be active against all test bacteria employed.

AB - The emergence of antibiotic resistance among pathogenic and commensal bacteria has become a serious problem worldwide. Use and overuse of antibiotics in a number of settings are contributing to the development of antibiotic-resistant microorganisms (1). Recently, the rate of discovery of new compounds from existing genera obtained from terrestrial sources has decreased, while the rate of re-isolation of known compounds has increased. Moreover, rise in the number of drug-resistant pathogens and limited success of strategies such as combinatorial chemistry in providing new agents indicates an uncertain forecast for future antimicrobial therapy (2, 3). Thus, it is critical that new groups of microbes from unexplored habitats be pursued as sources of novel antibiotics and other small-molecule therapeutic agents(4). In the present study 36 bacterial and 24 fungal isolates from different aqua to terrestrial sources were grown in broth culture for production of metabolites. The intracellular metabolites were extracted with methanol and extracellular metabolites were extracted with ethyl acetate. The crude intra and extracellular extracts were evaluated for antimicrobial activity by agar diffusion method using various bacterial and fungal test organisms. Ciprofloxacin (100 μg/ml) was used as standard for antibacterial studies and Nystatin disc (10 μg/disc) was used for antifungal studies. It was found that the isolate UG-3 (extracellular extract) showed both antibacterial and antifungal activity against all the test organisms employed. UG-6 was also equally promising, except that E.coli was resistant to the extracellular extract of UG-6. Intracellular extracts of MC-1, E-1, LS-4 , PSA-2 and extracellular extracts of M-4. LS-3F, GS-4, VHSS-2, LS-3XY, VHSP-5, PSA-3 were found to be active against all test organisms except Candida albicans. Extracellular extract of GS-1 and intracellular extracts of G-1, G-5, and K2A were found to be active against all test bacteria employed.

UR - http://www.scopus.com/inward/record.url?scp=65449166767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65449166767&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:65449166767

VL - 1

SP - 111

EP - 126

JO - Pharmacologyonline

JF - Pharmacologyonline

SN - 1827-8620

ER -